Canada - English - Health Canada

mylan pharmaceuticals ulc - vardenafil (vardenafil hydrochloride trihydrate) - tablet - 5mg - vardenafil (vardenafil hydrochloride trihydrate) 5mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

mylan pharmaceuticals ulc - vardenafil (vardenafil hydrochloride trihydrate) - tablet - 10mg - vardenafil (vardenafil hydrochloride trihydrate) 10mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

mylan pharmaceuticals ulc - vardenafil (vardenafil hydrochloride trihydrate) - tablet - 20mg - vardenafil (vardenafil hydrochloride trihydrate) 20mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

sanis health inc - vardenafil (vardenafil hydrochloride trihydrate) - tablet - 10mg - vardenafil (vardenafil hydrochloride trihydrate) 10mg - phosphodiesterase type 5 inhibitors

Canada - English - Health Canada

sanis health inc - vardenafil (vardenafil hydrochloride trihydrate) - tablet - 20mg - vardenafil (vardenafil hydrochloride trihydrate) 20mg - phosphodiesterase type 5 inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - vardenafil hydrochloride trihydrate, quantity: 11.852 mg (equivalent: vardenafil, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: magnesium stearate; aspartame; sorbitol; mannitol; crospovidone; silicon dioxide; flavour - levitra is indicated for the treatment of erectile dysfunction in adult males (inability to achieve or maintain penile erection sufficient for satisfactory sexual performance). levitra is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - vardenafil hydrochloride trihydrate, quantity: 23.7 mg - tablet, film coated - excipient ingredients: titanium dioxide; macrogol 8000; purified talc; iron oxide yellow; polyvinyl alcohol; magnesium stearate; iron oxide red; mannitol; colloidal anhydrous silica - vardenafil is indicated for the treatment of erectile dysfunction in adult males (inability to achieve or maintain penile erection sufficient for satisfactory sexual performance). vardenafil is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - vardenafil hydrochloride trihydrate, quantity: 11.85 mg - tablet, film coated - excipient ingredients: iron oxide yellow; titanium dioxide; magnesium stearate; mannitol; macrogol 8000; polyvinyl alcohol; purified talc; iron oxide red; colloidal anhydrous silica - vardenafil is indicated for the treatment of erectile dysfunction in adult males (inability to achieve or maintain penile erection sufficient for satisfactory sexual performance). vardenafil is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - vardenafil hydrochloride trihydrate, quantity: 5.925 mg - tablet, film coated - excipient ingredients: iron oxide red; polyvinyl alcohol; iron oxide yellow; magnesium stearate; colloidal anhydrous silica; macrogol 8000; purified talc; titanium dioxide; mannitol - vardenafil is indicated for the treatment of erectile dysfunction in adult males (inability to achieve or maintain penile erection sufficient for satisfactory sexual performance). vardenafil is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - vardenafil hydrochloride trihydrate, quantity: 5.925 mg - tablet, film coated - excipient ingredients: polyvinyl alcohol; macrogol 8000; iron oxide yellow; mannitol; colloidal anhydrous silica; magnesium stearate; iron oxide red; purified talc; titanium dioxide - vardenafil is indicated for the treatment of erectile dysfunction in adult males (inability to achieve or maintain penile erection sufficient for satisfactory sexual performance). vardenafil is not indicated for use by women.